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Maternal markers for detecting early-onset
neonatal infection and chorioamnionitis in cases
of premature rupture of membranes at or after
34 weeks of gestation: a two-center prospective
study
Thomas Popowski1*, François Goffinet1,2, Françoise Maillard1, Thomas Schmitz3, Sandrine Leroy1,4 and
Gilles Kayem1,5
Abstract
Background: Accurate prediction of infection, including maternal chorioamnionitis and early-onset neonatal
infection, remains a critical challenge in cases of preterm rupture of membranes and may influence obstetrical
management. The aim of our study was to investigate the predictive value for early-onset neonatal infection and
maternal histological and clinical chorioamnionitis of maternal biological markers in routine use at or after 34
weeks of gestation in women with premature rupture of membranes.
Methods: We conducted a two-center prospective study of all women admitted for premature rupture of
membranes at or after 34 weeks of gestation. The association of C-reactive protein, white blood cell count, vaginal
sample bacteriological results, and a prediction model at admission, for early-onset neonatal infection and maternal
chorioamnionitis were analyzed by comparing areas under the receiver operating characteristic curves and
specificity.
Results: The study included 399 women. In all, 4.3% of the newborns had an early-onset neonatal infection and
5.3% of the women had clinical chorioamnionitis. Histological chorioamnionitis was detected on 10.8% of 297
placentas tested. White blood cell counts and C-reactive protein concentrations were significantly associated with
early-onset neonatal infection and included in a prediction model. The area under the receiver operating
characteristic curve of this model was 0.82 (95% CI [0.72, 0.92]) and of C-reactive protein, 0.80 (95% CI [0.68, 0.92])
(p = 1.0). Specificity was significantly higher for C-reactive protein than for the prediction model (48% and 43%
respectively, p < 0.05). C-reactive protein was associated with clinical and histological chorioamnionitis, with areas
under the receiver operating characteristic curve of 0.61 (95% CI [0.48, 0.74]) and 0.62 (95% CI [0.47, 0.74]),
respectively.
Conclusions: The concentration of C-reactive protein at admission for premature rupture of membranes is the
most accurate infectious marker for prediction of early-onset neonatal infection in routine use with a sensitivity >
90%. A useful next step would be a randomized prospective study of management strategy comparing CRP at
admission with active management to assess whether this more individualized care is a safe alternative strategy in
women with premature rupture of membranes at or after 34 weeks.
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Background
Premature rupture of membranes (PROM) occurs in 8%
of pregnancies, 3% before and 5% after 37 weeks of
gestation [1]. Accurate prediction of infection, including
maternal chorioamnionitis and early-onset neonatal
infection (EONI), remains a critical challenge in these
cases. EONI, generally acquired prenatally in pregnan-
cies with PROM, is the most serious consequence of
maternal infection and is associated with increased neo-
natal morbidity and mortality [2,3].
Numerous studies in recent years have failed to iden-
tify a satisfactory prenatal marker of infection to predict
maternal chorioamnionitis and EONI. For these reasons,
guidelines for the management of women with PROM
do not take prenatal markers of infection into account
but are usually based on the gestational age at which
PROM occurs [4,5].
Many obstetricians therefore consider active manage-
ment, usually defined as the induction of labor in the 12
hours after PROM, as the best strategy for preventing
chorioamnionitis and EONI in cases of PROM at or
after 34 weeks [4,5]. Although a few studies have found
systematic active management at or after 34 weeks to be
advantageous for infectious outcomes [6,7], the choice
between active or expectant management at 34 to 36
weeks continues to be controversial because this strategy
may increase early delivery, which has been associated
with increased neonatal morbidity, behavioral disorders,
and health-care costs [8-12]. Furthermore, regardless of
gestational age, induction of labor is sometimes contra-
indicated for various reasons or situations, including
previous cesarean delivery and breech presentation.
Active management in these cases would increase the
rate of cesarean delivery.
The use of maternal laboratory markers at or after 34
weeks of gestation would help to distinguish women at
risk from those who do not require active management,
that is, for whom pregnancy can safely be prolonged.
Their use might make it possible to await spontaneous
labor and vaginal delivery and thus avoid cesareans
when induction is contraindicated or unsuccessful but
vaginal delivery remains appropriate. Prenatal maternal
markers of infection at or after 34 weeks have, however,
been insufficiently studied. Those that might be easily
used in routine care are serum C-reactive protein (CRP)
levels, white blood cell counts (WBC count), and bacter-
ial analysis of vaginal samples. No study has included
enough women at or after 34 weeks of gestation to
allow the predictive values of these markers to be
estimated.
Thus, our main objective was to investigate the pre-
dictive value for EONI and maternal histological and
clinical chorioamnionitis of CRP, WBC count, and the
bacteriological analysis of vaginal samples in routine use
at or after 34 weeks of gestation in women with PROM
and thus provide a safe alternative to systematic active
management.
Methods
Study design
This prospective hospital-based study conducted from
January 2004 through February 2006 in two French ter-
tiary university referral centers investigated the predic-
tive value of maternal serum and vaginal markers for
clinical and histological chorioamnionitis and for EONI.
This analysis included all women with PROM at or after
34 weeks of gestation in singleton pregnancies, except
those in spontaneous labor at admission and those who
gave birth more than 72 hours after admission. These
women were excluded to preserve the physiological tem-
poral effect between infectious markers at admission
and maternal-fetal infection. Clinical PROM was con-
firmed by an immunochromatographic dipstick test that
uses monoclonal antibodies to detect IGFBP-1 from
amniotic fluid.
A standardized form was used to collect data prospec-
tively at admission and thereafter. The attending physi-
cian obtained informed consent from all participants.
The study was approved by the relevant institutional
review board (CPP Ile de France).
Maternal serum samples were taken at admission
from all women. Antibiotic treatment was started at
admission for women if the third-trimester vaginal
sample contained group B Streptococci, and they were
not expectantly managed. Antibiotic treatment for all
other women began 12 hours after PROM. Amoxicillin
was administered except in cases of penicillin allergy,
when erythromycin was used instead. Women with a
clinical infection at admission were not included in the
study. One center used active management, defined by
induction of labor or cesarean delivery when induction
was contraindicated, in the 12 hours after PROM. The
other center used expectant management until 37
weeks, including clinical and laboratory monitoring for
infection; it also used expectant management at or
after 37 weeks for 48 hours after PROM, to promote
spontaneous vaginal delivery when possible and not
contraindicated.
This study was submitted to the French Ethical
Review Committee and was found to be in conformity
with the laws and regulations of the country in which
the research experiment was performed.
Outcome definitions
Three infectious outcomes were studied: EONI, clinical
chorioamnionitis and histological chorioamnionitis.
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EONI was defined by the pediatrician as a neonatal
infection within 72 hours after birth [13]. Confirmed
neonatal infections were defined by a positive blood cul-
ture or a positive cerebrospinal fluid culture associated
with clinical signs of infection. Probable neonatal infec-
tion was defined by clinical signs and a neonatal CRP ≥
10 mg/L. The final diagnosis of EONI was determined
after re-evaluation of the course of laboratory and clini-
cal markers through discharge.
Clinical chorioamnionitis was diagnosed by the attending
consultant physician responsible for management from
admission through delivery, according to the following cri-
teria: temperature greater than 37.8°C in a gravid patient
without evidence of urinary, respiratory, or other localized
infection, and any two of these other criteria: either uterine
tenderness or foul-smelling amniotic fluid, maternal tachy-
cardia greater than 120 beats per minute, and fetal tachy-
cardia, greater than 160 beats per minute [14].
Acute histological chorioamnionitis was defined as mild
or severe acute inflammatory changes in any relevant tis-
sue sample (amnion, chorion, decidua, umbilical cord, or
chorionic plate). For the histological analysis of the pla-
centa, tissue samples from the umbilical cord, chorionic
plate, and placental membranes were fixed in 10% neutral
buffered formalin and embedded in paraffin. Sections of
tissue blocks were stained with hematoxylin and eosin.
The pathologists in each center, blinded to the clinical
information, performed these examinations and classified
acute inflammation as minor, mild, or severe, on the basis
of the criteria of Salafia et al [15]. The histological analysis
of the placentas was standardized before the beginning of
the study by developing a common analysis protocol.
Predictive factors
Serum samples taken at admission were used to mea-
sure the maternal WBC count (expressed as cells × 109/
L) and CRP concentration (expressed as mg/L, assessed
by immunoturbidimetry). A vaginal swab sample was
also cultured to detect the standard pathogenic genital
bacteria according to groups II and III of a French clas-
sification (Additional file 1) [16,17].
Finally, we collected data about potential confounding
factors, including gestational age (in weeks of gestation at
admission), antibiotic prescription at admission, and type
of management (expectant or active). Active management
was defined as systematic delivery at admission, regardless
of gestational age, infectious status, or medical history.
Expectant management was defined as any other manage-
ment, including close monitoring for infectious status,
especially for women at 34 to 37 weeks of gestation.
Statistical Analysis
We first described the population’s characteristics and
then analyzed the relations between each of the three
infectious outcomes (EONI and clinical and histological
chorioamnionitis) and all the predictive factors with a
logistic regression model. When the relation between
the outcome and continuous variables (CRP and WBC
count) was not linear, the variables were transformed
into fractional polynomials of the lowest possible degree
[18]. Binary variables were coded as follows: abnormal
bacterial colonization of the genital tract: yes (1), no (0);
antibiotic prescription at admission (1), no antibiotic (0);
expectant management (1), and active management (0).
Because the model was not convergent when gestational
age was a continuous variable, it was dichotomized and
coded as it usually is in the literature: (1) for gestational
age at admission < 37 weeks gestation, (0) for ≥ 37
weeks. We first selected predictors that were signifi-
cantly associated with infectious outcome in the univari-
ate analysis, with a p value < 0.05. We then used a
backward stepwise technique, setting a p value > 0.1 for
removal from the model and calculating maximum like-
lihood ratio estimates. The model’s ability to discrimi-
nate between women with clinical chorioamnionitis,
those with histological chorioamnionitis, and those with
infants with EONI, compared with those without identi-
fied infection, was evaluated by the area under the ROC
curve and compared with that of the continuous vari-
ables that remained significant in the multivariable ana-
lysis. We next transformed the continuous probability of
the outcome given by the model into a binary test,
choosing a threshold based on the area under the ROC
curve that provided the best specificity with at least 90%
sensitivity. The performance of the model was deter-
mined by calculating sensitivity, specificity, and positive
and negative likelihood ratios.
Internal cross-validation of the final model was per-
formed by bootstrapping (100 times), a computer-inten-
sive statistical method and resampling technique based
on random samples of observations to estimate error by
systematically recomputing the statistics while omitting
one observation at a time from the sample set [19].
Using the same pre-specified 90% sensitivity, we dichot-
omized continuous predictors into binary variables and
used a paired c2 test to compare their discriminative
abilities to those of the model.
Statistical analyses were performed with Stata 10/SE
software (StataCorp, College Station, TX, USA) and
Confidence Interval Analysis software (London, UK)
[20].
Results
During the study period, 627 women were admitted for
PROM, 434 of them at or after 34 weeks of gestation
(Figure 1). Among the latter, 399 gave birth within 72
hours after admission and were therefore included in
the final analysis; 57 (14.3%) had PROM before 37
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weeks, 21 (5.3%) had clinical chorioamnionitis, and 32
histological chorioamnionitis (10.8% of the 297 women
for whom histological analysis was available). EONI was
diagnosed for 17 (4.3%) newborns, including six (35.3%)
whose mothers had clinical chorioamnionitis and six
(35.3%) whose mothers had histological chorioamnioni-
tis (including one whose mother had both). Mean gesta-
tional age at PROM was 38.5 weeks. The characteristics
of women and their babies are summarized in Table 1.
Overall, 128 women (32.1%) had active management
and 271 (67.9%) expectant management, that is, sponta-
neous deliveries. Among the latter, 211 (78%) took place
within 12 hours after admission. Overall, only 57 of the
399 women (14%) were delivered at 34-36 weeks: one
had clinical chorioamnionitis, five histological chorioam-
nionitis, and 2 had a neonate with an EONI. These fig-
ures are unfortunately too low to allow a useful
statistical analysis for this subgroup.
As expected, spontaneous delivery rates differed
according to center. In the center that provided an
expectant management policy for 48 hours for women
after 37 weeks, 76% of the women gave birth after spon-
taneous delivery, but only 56% of the women in the cen-
ter with active management, all of those within the first
12 hours after PROM. Neither EONI (p = 0.12) nor
clinical chorioamnionitis (p = 0.30) rates differed
between the two centers. Histological chorioamnionitis
was observed more often in the center with expectant
compared with active management (p = 0.042). The
cesarean rates were 18.0% (42/233) and 19.3% (32/166)
(p = 0.75).
Table 2 reports the relations between infectious out-
comes and all predictive factors. We observed no con-
founding factors; in particular, neither gestational age
nor type of management was significantly associated
with any of the three infectious outcomes. Because the
association between WBC count and EONI was not lin-
ear (p = 0.004), we studied it by transforming the WBC
count into a first-degree fractional polynomial function.
In a univariate analysis, WBC count, CRP, and abnormal
bacterial colonization of the genital tract were all asso-
ciated with EONI. In a multivariable analysis after step-
wise reduction, WBC count and CRP remained
significantly associated with EONI (Table 2). The model
fit was good (p = 0.54, Hosmer and Lemeshow test).
Using the coefficients assigned to each predictor in the
logistic regression model, we derived a prediction model
as follows: logit (predicted probability of infant with
EONI) = -4.047 + 0.055*CRP + 0.013*[(WBC count/
10000)^7.6354 - 1.660, where EONI was coded (0) if
absent and (1) if present. The area under the ROC curve
of the EONI prediction model was significantly higher
than that of WBC count (0.82, 95% CI [0.72, 0.92] vs 0.62
[0.45, 0.78], p = 0.003) but not than that of CRP (0.82
[0.72, 0.92] vs 0.80 [0.68, 0.92], p = 1.0) (Figure 2).
Next, we used ROC curves to define the threshold
corresponding to our pre-specified sensitivity of at least
90%, which allowed us to transform the continuous
probability of EONI into a binary rule. A positive result
according to this rule (corresponding to a predicted
probability ≥ 0.022) was significantly associated with
EONI (OR = 12.0 [1.6, 91.7]) and had a sensitivity of
94% (77, 99%), a specificity of 43% (38, 47%), a positive
likelihood ratio of 1.6 (1.5, 1.9), and a negative likeli-
hood ratio of 0.1 (0.1, 0.7) for the prediction of EONI
(Table 3).
We applied the same pre-specified constraint of a sen-
sitivity of at least 90% to dichotomize the only
627"women"with"PROM"included"in"the"original"
prospective"study"with"available"markers
467"women"with"PROM"
33"women"with"multiple"pregnancies"
434"women"with"singleton"pregnancies
160"women"with"preterm"PROM"
35"deliveries"more"than"72"h"after"
399women"included"in"the"final"
analysis"
- 34"to"37"WG:"57"(14.3%)
Figure 1 Flow chart of the study population. Abbreviations:
PROM, Premature rupture of membranes; WG, Weeks of gestation.
Table 1 Maternal and neonatal characteristics
Women N = 399
Maternal age, years (mean +/- [SD]) 31.7 +/- [5.5]
Nulliparous, n (%) 214 (53.8)
Gestational age at inclusion in study (weeks)
(mean +/- [SD])
38.5 +/-[1.6]
Time elapsed from admission to delivery (hours)
(mean +/- [SD])
25 +/- [15]
Active management, n (%) 128 (32.1)
Expectant management, n (%) 271 (67.9)
Histological chorioamnionitis, n (%) (N = 297) 32 (10.8)
Funiculitis, n (%) (N = 297) 14 (4.7)
Neonates N = 399
Birth weight (grams) (mean +/- [SD]) 3240 +/- [471]
Early-onset neonatal infection, n (%) 17 (4.3)
5-minutes Apgar score < 7, n (%) 14 (3.5)
Transfer to neonatal intensive care unit, n (%) 14 (3.5)
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significant independent predictor, CRP, at a threshold of
5 mg/L. Elevated CRP (≥ 5 mg/L) was then significantly
associated with EONI (OR = 14.7 [1.9, 112.2]), with a
sensitivity of 94% (73-99), a specificity of 48% (43-53), a
positive likelihood ratio of 1.8 (1.6, 2.1), and a negative
likelihood ratio of 0.1 (0.0, 0.8) for the prediction of
EONI (Table 3 and Figure 3). Lastly, the specificity of
CRP alone was significantly higher than that of the pre-
diction model (significant difference of 5% (2, 8%)).
Table 2 Crude and adjusted association between EONI, clinical and histological chorioamnionitis and gestational age
at delivery, antibiotics at admission, management of delivery, and routinely used infectious markers
Early Onset Neonatal Infection Clinical Chorioamnionitis Histological Chorioamnionitis
Binary Variables OR
[95% CI]
Adjusted OR
[95% CI]a
OR
[95% CI]
Adjusted OR
[95% CI]a
OR
[95% CI]
Adjusted OR
[95% CI]a
Gestational Age
< 37 0.8 [0.2, 3.6] - 0.3 [0.0, 2.2] - 1.1 [0.4, 3.1] -
≥ 37 1 1 1
Antibiotic at admission
Yes 0.7 [0.3, 2.1] - 0.5 [0.2, 1.5] - 0.6 [0.2, 1.3] -
No 1 1 1
Management of delivery
Expectant 0.4 [0.1, 1.6] - 0.6 [0.2, 1.8] - 1.6 [0.8, 3.5] -
Active 1 1 1
Abnormal bacterial colonisation, genital tract
Yes 2.7 [1.0, 7.2] 2.2 [0.7, 6.6] 1.8 [0.7, 4.6] - 1.2 [0.5, 2.7] -
No 1 1 1 1
Continuous variablesb Coefficient
[95% CI]
Adjusted Coefficient
[95% CI]a
Coefficient
[95% CI]
Adjusted Coefficient
[95% CI]a
Coefficient
[95% CI]
Adjusted Coefficient
[95% CI]a
CRP(mg/l) 0.064
[0.035, 0.093]
0.055
[0.024, 0.086]
0.039
[0.016, 0.062]
0.039
[0.016, 0.062]
0.051
[0.022, 0.080]
0.051
[0.022, 0.080]
WBC (giga/l) 0.015
[0.007, 0.023]
0.013
[0.003, 0.022]c
0.0001
[-0.0001, 0.0002]
- 0.0001
[0.00003, 0.0002]
-
a Adjusted OR and coefficients for non-significant variables taken from the model just before their elimination after stepwise reduction; those for
significant variables come from the final model
b Coefficients for CRP and WBC were calculated from the logistic regression equation.
c The FP1 transformation used for WBC because of its non-linear association with EONI was: [(WBC/10000)7.6354-1.660493995].
0.00"
0.25"
0.50
0.75
1.00
Sensitivity"
0.00 0.25" 0.50 0.75 1.00
1-Specificity
Areas"under"ROC"curve:"
Prediction"model"="0.82 [0.72,"0.92]
CRP"="0.80"[0.68,"0.92]"
WBC"="0.62"[0.45,"0.78]
Figure 2 Comparison of ROC curves of prediction model,
maternal serum CRP, and WBC for predicting EONI.
Table 3 Predictive value of the model and CRP for EONI
Prediction Model
(≥ 0.022265)
[95% CI]
CRP
(≥ 5 mg/l)
[95% CI]
Sensitivity 94 [77-99] 94 [73-99]
Specificity 43 [38-47] 48 [43-53]
PPV 7 [5-10] 7 [5-12]
NPV 99 [97-100] 100 [97-100]
Positive LR 1.6 [1.5-1.9] 1.8 [1.6-2.1]
Negative LR 0.1 [0.1-0.7] 0.1 [0.0-0.8]
OR 12.0 [1.6-91.7] 14.7 [1.9-112.2]
LR, likelihood ratio
NPV, negative predictive value
PPV, positive predictive value
OR, odds ratio
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Internal cross-validation by bootstrapping showed that
dichotomized CRP had a stable predictive value for
EONI, with a sensitivity of 94% (82, 100%) and a specifi-
city of 47% (42, 54%). The results for the prediction
model were also stable after internal cross-validation,
with a sensitivity of 94% (82, 100%) and a specificity of
43% (39, 47%).
CRP was the only factor significantly associated with
both clinical and histological chorioamnionitis, and it
was linearly associated with these outcomes. Areas
under the ROC curves were 0.61 (0.48, 0.74) for clinical
and 0.62 (0.47, 0.74) for histological chorioamnionitis
(Figure 4). With a cut-off of 5 mg/L, the predictive
values of CRP for clinical chorioamnionitis were 71%
(48, 89%) (sensitivity) and 47% (42, 52%) (specificity),
with positive and negative likelihood ratios of 1.4 (1.0,
1.8) and 0.6 (0.3, 1.2). For histological chorioamnionitis,
sensitivity was 59% (41, 76%), and specificity 47% (41,
53%), with positive and negative likelihood ratios of 1.1
(0.8, 1.5) and 0.9 (0.6, 1.4).
Discussion
Of the routinely tested prenatal markers, a CRP concen-
tration of 5 mg/L or more was the most accurate pre-
dictor of EONI, with a sensitivity of 94% and a
specificity of 47%. Its predictive value was not improved
by including it in a prediction model with WBC count.
A CRP concentration of 5 mg/L or more was also asso-
ciated with both clinical and histological chorioamnioni-
tis, but its predictive values for both outcomes were low.
This study is, to our knowledge, the first to investigate
prenatal markers in women with PROM at or after 34
weeks of gestation and the largest prospective cohort
study of serum infectious markers in PROM. In a retro-
spective study including 90 women with PROM from 23
to 41 weeks of gestation, Yoon et al. did not find that
either CRP or WBC count had a high predictive value
for histological chorioamnionitis [21].
The ability to predict EONI is a high priority for phy-
sicians managing women with PROM, because it is the
main cause of neonatal morbidity and mortality when
PROM occurs at or after 34 weeks [2,3]. We used a pre-
specified high sensitivity because the aim of this study
was to select a population with a very low risk of infec-
tion, who could safely avoid systematic active manage-
ment. The negative predictive value of the test is
important, regardless of its specificity. In fact, systematic
active management is a strategy with 0% specificity;
compared to it, a specificity of 47% is a good result,
Figure 3 Distribution of EONI as a function of continuous CRP
(horizontal line: CRP = 5 mg/l).
Clinical Chorioamnionitis (CCA)                             Histological Chorioamnionitis (HCA) 
0.00
0.25
0.50
0.75
1.00
Sensitivity
0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.61 [0.48, 0.74]
0.00
0.25
0.50
0.75
1.00
Sensitivity
0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.62 [0.47, 0.74]
Figure 4 ROC curves of maternal serum CRP for predicting clinical and histological chorioamnionitis.
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with nearly half the women safely able to avoid systema-
tic active management.
The choice between immediate active or expectant
management for women with PROM from 34 to 37
weeks of gestation remains controversial [6,7,22]. Guide-
lines in many countries advocate active management,
mainly because of the risk of neonatal infection [4,5].
This strategy, however, may increase the rate of moder-
ately preterm birth, which is associated with significant
neonatal morbidity [10-12]. It may also increase the
cesarean rate among women for whom induction of
labor is contraindicated (or unsuccessful). A survey,
published in 2004 and including 508 specialists from all
50 of the United States and 13 other countries, showed
that the gestational age at which expectant management
is rejected in women with preterm PROM varied signifi-
cantly between respondents: ≥ 34 weeks for 56%, ≥ 35
weeks for 26%, ≥ 36 weeks for 12%, and ≥ 37 weeks for
4.0% [8]. Canadian and Australian surveys show a simi-
lar lack of medical consensus on management from 34
to 36 weeks [9,23].
A recent systematic review included seven rando-
mized controlled trials (690 women) and compared
expectant management with early delivery for women
with preterm PROM before 37 weeks of gestation
(from 25 to 36 weeks) [24]. It identified no difference
in neonatal sepsis (RR = 1.3 (0.7, 2.5)) or neonatal
respiratory distress (RR = 1.0 (0.7, 1.3)) but found that
active management significantly reduced suspected
neonatal infection (RR = 0.5 (0.3, 0.8)). Moreover,
active management seemed to have no effect on clini-
cal chorioamnionitis (RR = 0.4 (0.2, 1.1)) but was asso-
ciated with a significant increase in the cesarean rate
(RR = 1.5 (1.1, 2.1)) [24]. The authors concluded that
there is insufficient evidence about the benefits and
disadvantages of immediate delivery, compared with
expectant management, for women with preterm
PROM. Dare et al. conducted a systematic review that
finally included 12 randomized or quasi-randomized
trials comparing planned early birth with expectant
management in women with PROM at or after 37
weeks of gestation. They concluded that clinical chor-
ioamnionitis was significantly less frequent among
women with active management compared with those
expectantly managed (RR = 0.7 (0.6, 1.0)), but they
observed no difference for neonatal infection (RR = 0.8
(0.6, 1.1)) [22]. From our perspective, these findings
underline the uncertainty related to PROM manage-
ment after 34 weeks of gestation and emphasize the
need for a predictive strategy to support individualized
care based on the individual risk of infection.
Our methodology was selected to reduce bias as much
as possible. We analyzed all continuous variables
without dichotomizing them to reduce analytic bias
[25]. A bootstrap resampling procedure was used to
reduce the over-fit of the statistical model on the study
population [19]. To prevent any bias related to gesta-
tional age, antibiotic prescriptions, or medical manage-
ment, we adjusted for these factors in our multivariable
model. A meaningful temporal relation between infec-
tious markers and the primary outcome was preserved
by including only those women who gave birth within
72 hours after admission [26]. The 35 women who
delivered more than 72 hours after admission (8.0%)
were excluded from the study. This subgroup’s charac-
teristics did not differ significantly from those of women
finally included in the study and no differences between
the groups were observed for EONI (p = 0.69) or for
clinical (p = 0.14) or histological chorioamnionitis (p =
0.06). Nonetheless, we did observe a trend to chorioam-
nionitis in this group with later deliveries, but lack of
power prevented a definitive result. Our study shows
that a CRP concentration of 5 mg/L or higher predicts
EONI with high sensitivity. Measured routinely at
admission, CRP may be useful for selecting a population
among whom the risk of EONI contraindicates expec-
tant management. In our study, consideration of CRP at
admission would have led to active management of 215
women (54%); including 16 whose infants had EONI
(94%). The remaining 184 women could have been man-
aged expectantly: most of them (almost 90%) went into
labor spontaneously within 72 hours, and only one neo-
nate had EONI [27,28]. Although the systematic active
management in one center might be considered a lim-
itation of this study, our results suggest that maternal
serum CRP could be a safe alternative strategy to sys-
tematic active management, especially in cases of pre-
vious cesarean deliveries, or breech presentation, or in
women with PROM near term. Given that the strategy
of systematic active management has 0% specificity and
in view of our findings, nearly half the cases could safely
avoid systematic active management. Our results call for
a randomized trial, to compare immediate systematic
active management in PROM at and after 34 weeks of
gestation with management according to maternal
serum CRP.
Conclusions
Maternal serum CRP at admission is the most accurate
infectious marker for predicting EONI that is currently
in routine use. A useful next step would be a rando-
mized prospective study of management strategy com-
paring CRP at admission with active management to
assess whether this more individualized care is a safe
alternative strategy in women with premature rupture of
membranes at or after 34 weeks.
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